CompletedNot Applicable

Optimal Placement Duration of Pancreatic Duct Stent

South Korea122 participantsStarted 2021-02-01

Plain-language summary

A randomized controlled trial to determine the optimal placement duration of pancreatic duct stents (PDS) inserted during ERCP: 2 vs 4 weeks

Who can participate

Age range20 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients who underwent the pancreatic duct stent placement during ERCP Exclusion Criteria: * Patients who had pancreatic duct stent for the purpose of pancreatic interventions * Patients who underwent simultaneous bile duct stenting

What they're measuring

Number of participants with undergoing endoscopic procedures

Timeframe: 2 weeks (control group) or 4 weeks (study group) following ERCP

Trial details

NCT IDNCT04691674

SponsorDongGuk University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-31

View on ClinicalTrials.gov More Cholangitis trials